Curcumin Improves Chronic Pain Induced Depression Through Regulating Serum Metabolomics in a Rat Model of Trigeminal Neuralgia

References

• Zhang M, Liu Y, Zhao M, et al. Depression and anxiety behaviour in a rat model of chronic migraine. J Headache Pain. 2017;18(1):27. doi:10.1186/s10194-017-0736-z
   PubMed Web of Science ®Google Scholar
• Shi M, Wang JY, Luo F. Depression shows divergent effects on evoked and spontaneous pain behaviors in rats. j Pain. 2010;11(3):219–229. doi:10.1016/j.jpain.2009.07.002
   Web of Science ®Google Scholar
• Baune BT, Miller R, McAfoose J, Johnson M, Quirk F, Mitchell D. The role of cognitive impairment in general functioning in major depression. Psychiatry Res. 2010;176(2–3):183–189. doi:10.1016/j.psychres.2008.12.001
   PubMed Web of Science ®Google Scholar
• Felix RH, Almeida CB, Cremaschi RC, Coelho FM, Santos FC. Pain-induced depression is related to overestimation of sleep quality in a very elderly population with pain. Arq Neuropsiquiatr. 2017;75(1):25–29. doi:10.1590/0004-282x20160186
   Web of Science ®Google Scholar
• Apkarian AV, Sosa Y, Sonty S, et al. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci. 2004;24(46):10410–10415. doi:10.1523/JNEUROSCI.2541-04.2004
   PubMed Web of Science ®Google Scholar
• Grachev ID, Fredrickson BE, Apkarian AV. Abnormal brain chemistry in chronic back pain: an in vivo proton magnetic resonance spectroscopy study. Pain. 2000;89(1):7–18. doi:10.1016/S0304-3959(00)00340-7
   PubMed Web of Science ®Google Scholar
• Egloff N, Wegmann B, Juon B, Stauber S, von Kanel R, Vogelin E. The impact of anxiety and depressive symptoms on chronic pain in conservatively and operatively treated hand surgery patients. J Pain Res. 2017;10:259–263. doi:10.2147/JPR.S116674
   Web of Science ®Google Scholar
• O’Gorman A, Brennan L. The role of metabolomics in determination of new dietary biomarkers. Proc Nutr Soc. 2017;76(3):295–302. doi:10.1017/S0029665116002974
   Web of Science ®Google Scholar
• Allard PM, Genta-Jouve G, Wolfender JL. Deep metabolome annotation in natural products research: towards a virtuous cycle in metabolite identification. Curr Opin Chem Biol. 2017;36:40–49. doi:10.1016/j.cbpa.2016.12.022
   PubMed Web of Science ®Google Scholar
• Lestari ML, Indrayanto G. Curcumin. Profiles Drug Subst Excip Relat Methodol. 2014;39:113–204.
   PubMedGoogle Scholar
• Mahady GB, Pendland SL, Yun G, Lu ZZ. Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen. Anticancer Res. 2002;22(6c):4179–4181.
   PubMed Web of Science ®Google Scholar
• Reddy RC, Vatsala PG, Keshamouni VG, Padmanaban G, Rangarajan PN. Curcumin for malaria therapy. Biochem Biophys Res Commun. 2005;326(2):472–474. doi:10.1016/j.bbrc.2004.11.051
   PubMed Web of Science ®Google Scholar
• Vera-Ramirez L, Pérez-Lopez P, Varela-Lopez A, Ramirez-Tortosa M, Battino M, Quiles JL. Curcumin and liver disease. Biofactors. 2013;39(1):88–100. doi:10.1002/biof.1057
   PubMed Web of Science ®Google Scholar
• Wright LE, Frye JB, Gorti B, Timmermann BN, Funk JL. Bioactivity of turmeric-derived curcuminoids and related metabolites in breast cancer. Curr Pharm Des. 2013;19(34):6218–6225. doi:10.2174/1381612811319340013
   PubMed Web of Science ®Google Scholar
• Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013;15(1):195–218. doi:10.1208/s12248-012-9432-8
   PubMed Web of Science ®Google Scholar
• Kulkarni SK, Bhutani MK, Bishnoi M. Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology. 2008;201(3):435–442. doi:10.1007/s00213-008-1300-y
   PubMed Web of Science ®Google Scholar
• Wang R, Xu Y, Wu HL, et al. The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors. Eur J Pharmacol. 2008;578(1):43–50. doi:10.1016/j.ejphar.2007.08.045
   Web of Science ®Google Scholar
• Lin TY, Lu CW, Wang CC, Wang YC, Wang SJ. Curcumin inhibits glutamate release in nerve terminals from rat prefrontal cortex: possible relevance to its antidepressant mechanism. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(7):1785–1793. doi:10.1016/j.pnpbp.2011.06.012
   Web of Science ®Google Scholar
• Zhang L, Xu T, Wang S, et al. Curcumin produces antidepressant effects via activating MAPK/ERK-dependent brain-derived neurotrophic factor expression in the amygdala of mice. Behav Brain Res. 2012;235(1):67–72. doi:10.1016/j.bbr.2012.07.019
   PubMed Web of Science ®Google Scholar
• An JX, He Y, Qian XY, et al. A new animal model of trigeminal neuralgia produced by administration of cobra venom to the infraorbital nerve in the rat. Anesth Analg. 2011;113(3):652–656. doi:10.1213/ANE.0b013e3182245add
   Web of Science ®Google Scholar
• Zhao X, Wang C, Zhang JF, et al. Chronic curcumin treatment normalizes depression-like behaviors in mice with mononeuropathy: involvement of supraspinal serotonergic system and GABAA receptor. Psychopharmacology. 2014;231(10):2171–2187. doi:10.1007/s00213-013-3368-2
   PubMed Web of Science ®Google Scholar
• Wu Z, Qian XY, An JX, et al. Trigeminal neuralgia induced by cobra venom in the rat leads to deficits in abilities of spatial learning and memory. Pain Phys. 2015;18(2):E207–216.
   Web of Science ®Google Scholar
• Zhang L, Ding X, Wu Z, Wang M, Tian M. Curcumin alleviates pain and improves cognitive impairment in a rat model of cobra venom-induced trigeminal neuralgia. J Pain Res. 2018;11:1095–1104. doi:10.2147/JPR.S162668
   Web of Science ®Google Scholar
• Wang J, Goffer Y, Xu D, et al. A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats. Anesthesiology. 2011;115(4):812–821. doi:10.1097/ALN.0b013e31822f16ae
   PubMed Web of Science ®Google Scholar
• Ma X, Chi YH, Niu M, et al. Metabolomics coupled with multivariate data and pathway analysis on potential biomarkers in cholestasis and intervention effect of paeonia lactiflora pall. Front Pharmacol. 2016;7:14. doi:10.3389/fphar.2016.00014
   PubMed Web of Science ®Google Scholar
• Goesling J, Clauw DJ, Hassett AL. Pain and depression: an integrative review of neurobiological and psychological factors. Curr Psychiatry Rep. 2013;15(12):421. doi:10.1007/s11920-013-0421-0
   PubMed Web of Science ®Google Scholar
• Singh L, Kaur A, Garg S, Bhatti R. Skimmetin/osthole mitigates pain-depression dyad via inhibiting inflammatory and oxidative stress-mediated neurotransmitter dysregulation. Metab Brain Dis. 2020. doi:10.1007/s11011-020-00604-4
   Web of Science ®Google Scholar
• Arroba AI, Mazzeo A, Cazzoni D, et al. Somatostatin protects photoreceptor cells against high glucose-induced apoptosis. Mol Vis. 2016;22:1522–1531.
   PubMed Web of Science ®Google Scholar
• Capo-chichi CD, Gueant JL, Lefebvre E, et al. Riboflavin and riboflavin-derived cofactors in adolescent girls with anorexia nervosa. Am J Clin Nutr. 1999;69(4):672–678. doi:10.1093/ajcn/69.4.672
   Web of Science ®Google Scholar
• Sjoberg S, Eriksson M, Nordin C. L-thyroxine treatment and neurotransmitter levels in the cerebrospinal fluid of hypothyroid patients: a pilot study. Eur j Endocrinol. 1998;139(5):493–497. doi:10.1530/eje.0.1390493
   Web of Science ®Google Scholar
• Chandurkar V, Shik J, Randell E. Exacerbation of underlying hypothyroidism caused by proteinuria and induction of urinary thyroxine loss: case report and subsequent investigation. Endocrine Pract. 2008;14(1):97–103. doi:10.4158/EP.14.1.97
   Google Scholar
• Scheich B, Gaszner B, Kormos V, et al. Somatostatin receptor subtype 4 activation is involved in anxiety and depression-like behavior in mouse models. Neuropharmacology. 2016;101:204–215. doi:10.1016/j.neuropharm.2015.09.021
   Web of Science ®Google Scholar
• Dang VT, Huang A, Zhong LH, Shi Y, Werstuck GH. Comprehensive plasma metabolomic analyses of atherosclerotic progression reveal alterations in glycerophospholipid and sphingolipid metabolism in apolipoprotein E-deficient Mice. Sci Rep. 2016;6:35037. doi:10.1038/srep35037
   Web of Science ®Google Scholar
• Romay MC, Che N, Becker SN, et al. Regulation of NF-kappaB signaling by oxidized glycerophospholipid and IL-1beta induced miRs-21-3p and −27a-5p in human aortic endothelial cells. J Lipid Res. 2015;56(1):38–50. doi:10.1194/jlr.M052670
   Web of Science ®Google Scholar
• Liu XJ, Zhou YZ, Li ZF, et al. Anti-depressant effects of Xiaoyaosan on rat model of chronic unpredictable mild stress: a plasma metabonomics study based on NMR spectroscopy. J Pharm Pharmacol. 2012;64(4):578–588. doi:10.1111/j.2042-7158.2011.01412.x
   Web of Science ®Google Scholar
• Małecki A, Małecka E, Trzeciak HI. [Gangliosides in neurological pharmacotherapy]. Neurol Neurochir Pol. 1992;26(5):695–701. [Article in Polish].
   Google Scholar
• Gronnier J, Germain V, Gouguet P, Cacas JL, Mongrand S. GIPC: glycosyl Inositol Phospho Ceramides, the major sphingolipids on earth. Plant Signal Behav. 2016;11(4):e1152438. doi:10.1080/15592324.2016.1152438
   PubMedGoogle Scholar
• Jiang B, Song L, Wang CN, Zhang W, Huang C, Tong LJ. Antidepressant-like effects of GM1 ganglioside involving the BDNF signaling cascade in mice. Int j Neuropsychopharmacol. 2016;19:9. doi:10.1093/ijnp/pyw046
   Web of Science ®Google Scholar
• Wu Y, Tang J, Zhou C, et al. Quantitative proteomics analysis of the liver reveals immune regulation and lipid metabolism dysregulation in a mouse model of depression. Behav Brain Res. 2016;311:330–339. doi:10.1016/j.bbr.2016.05.057
   Web of Science ®Google Scholar
• Rolo AP, Palmeira CM, Holy JM, Wallace KB. Role of mitochondrial dysfunction in combined bile acid-induced cytotoxicity: the switch between apoptosis and necrosis. Toxicol Sci. 2004;79(1):196–204. doi:10.1093/toxsci/kfh078
   Web of Science ®Google Scholar
• Watanabe N, Kagawa T, Kojima S, et al. Taurolithocholate impairs bile canalicular motility and canalicular bile secretion in isolated rat hepatocyte couplets. World j Gastroenterol. 2006;12(33):5320–5325. doi:10.3748/wjg.v12.i33.5320
   Web of Science ®Google Scholar
• Goto J. [Chromatographic determination of bile acids in biological fluids with sensitive and selective detection]. Yakugaku Zassh. 1990;110(11):807–821. [Article in Japanese]. doi:10.1248/yakushi1947.110.11_807
   Web of Science ®Google Scholar
• Khatri DK, Juvekar AR. Kinetics of inhibition of monoamine oxidase using curcumin and ellagic acid. Pharmacogn Mag. 2016;12(Suppl 2):S116–120. doi:10.4103/0973-1296.182168
   Web of Science ®Google Scholar
• Kulkarni SK, Dhir A. An overview of curcumin in neurological disorders. Indian J Pharm Sci. 2010;72(2):149–154. doi:10.4103/0250-474X.65012
   PubMed Web of Science ®Google Scholar
• Chang XR, Wang L, Li J, Wu DS. Analysis of anti-depressant potential of curcumin against depression induced male albino wistar rats. Brain Res. 2016;1642:219–225. doi:10.1016/j.brainres.2016.03.010
   PubMed Web of Science ®Google Scholar
• Jangra A, Kwatra M, Singh T, et al. Piperine augments the protective effect of curcumin against lipopolysaccharide-induced neurobehavioral and neurochemical deficits in mice. Inflammation. 2016;39(3):1025–1038. doi:10.1007/s10753-016-0332-4
   PubMed Web of Science ®Google Scholar
• Bortolato B, Miskowiak KW, Kohler CA, et al. Cognitive remission: a novel objective for the treatment of major depression? BMC Med. 2016;14:9. doi:10.1186/s12916-016-0560-3
   PubMed Web of Science ®Google Scholar
• Mittal N, Joshi R, Hota D, Chakrabarti A. Evaluation of antihyperalgesic effect of curcumin on formalin-induced orofacial pain in rat. Phytother Res. 2009;23(4):507–512. doi:10.1002/ptr.2662
   Web of Science ®Google Scholar
• Ng QX, Koh SSH, Chan HW, Ho CYX. Clinical use of curcumin in depression: a meta-analysis. J Am Med Dir Assoc. 2017;18(6):503–508. doi:10.1016/j.jamda.2016.12.071
   PubMed Web of Science ®Google Scholar
• Choi GY, Kim HB, Hwang ES, et al. Curcumin alters neural plasticity and viability of intact hippocampal circuits and attenuates behavioral despair and COX-2 expression in chronically stressed rats. Mediators Inflamm. 2017;2017:6280925. doi:10.1155/2017/6280925
   Web of Science ®Google Scholar
• Kaufmann FN, Gazal M, Bastos CR, Kaster MP, Ghisleni G. Curcumin in depressive disorders: an overview of potential mechanisms, preclinical and clinical findings. Eur J Pharmacol. 2016;784:192–198. doi:10.1016/j.ejphar.2016.05.026
   Web of Science ®Google Scholar
• Al-Karawi D, Al Mamoori DA, Tayyar Y. The role of curcumin administration in patients with major depressive disorder: mini meta-analysis of clinical trials. Phytother Res. 2016;30(2):175–183. doi:10.1002/ptr.5524
   PubMed Web of Science ®Google Scholar
• Fusar-Poli L, Vozza L, Gabbiadini A, et al. Curcumin for depression: a meta-analysis. Crit Rev Food Sci Nutr. 2020;60(15):2643–2653. doi:10.1080/10408398.2019.1653260
   PubMed Web of Science ®Google Scholar
• Patti GJ, Yanes O, Shriver LP, et al. Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin. Nat Chem Biol. 2012;8(3):232–234. doi:10.1038/nchembio.767
   PubMed Web of Science ®Google Scholar